Millions of people have lost weight on GLP-1s. But the drugs can also cause significant loss of muscle mass. The fitness industry is responding with tailored workouts that cater to these clients. The ...

Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...

When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic. Instead of paying more than $1,000 out of pocket for the Type 2 ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug Administration ...

The popularity of GLP-1 receptor agonists have prompted some trainers to offer regimens that specifically deal with the side effects of the resulting rapid weight loss. Here personal trainer Mike ...

Ozempic is a drug that can help with weight loss. However, some people may experience “Ozempic rebound.” This refers to regaining weight and reversing the health benefits after they stop using the ...

Ozempic can flatten butts and maybe extinguish them, too! Taking Ozempic or its sister drug Wegovy may help some smokers kick the habit, new research suggests. The study compares the effects of eight ...

Anecdotal reports and a case series suggest that Ozempic and other GLP-1 receptor agonists may in some cases lead to underproduction of saliva and a dry mouth. (Photo: Getty) People have been mouthing ...

Ozempic can cause people to feel tired, but this was a rare side effect in the drug’s studies. Tiredness or fatigue may also be a symptom of other Ozempic side effects. Fatigue (tiredness or low ...

Some people using semaglutide (Ozempic, others) have noticed sagging skin in the buttocks after losing weight, calling it “Ozempic butt.” While lifestyle modifications may help prevent this side ...

There is multidistrict litigation, or an MDL, in progress against pharmaceutical companies Novo Nordisk and Eli Lilly and Co. from parties allegedly suffering side effects caused by the active ...